Researchers have developed a new non-human primate (NHP) animal model to study Crimean-Congo hemorrhagic fever (CCHF), a viral disease spread by ticks in the Middle East, Asia, Africa and parts of Europe. [Read more]
The Nonclinical Studies Network is a key element in the successful development of U.S. medical countermeasures for biological threats, particularly since efficacy of products directed against most of these threats cannot be [Read more]
Scientists from NIH’s National Institute of Allergy and Infectious Diseases, working with colleagues from the University of Washington and Columbia University, have published study results on a new Ebola virus (EBOV) mouse [Read more]
The FDA’s Center for Drug Evaluation and Research is seeking input from the public and private sectors on research ideas to facilitate the development of drugs to help mitigate antibiotic resistance. There [Read more]
See what we’re reading this week at Global Biodefense on topics including pandemic simulations, Canada’s anthrax vaccine stockpile, animal feed biosecurity, and CRISPR’s promise for better animal models. BIOPREPAREDNESS Assessing the epidemic potential of [Read more]
The National Heart, Lung, and Blood Institute (NHLBI) this week provided an update to its research topics of special interest for funding via Small Business Technology Transfer (STTR) and Small Business Innovation [Read more]
The U.S. Army’s Walter Reed Army Institute of Research (WRAIR) and Sanofi Pasteur this week announced a collaborative agreement for the development of a Zika vaccine candidate. WRAIR scientists and collaborators are [Read more]
The 2009 swine H1N1 flu pandemic — responsible for more than 17,000 deaths worldwide — originated in pigs from a very small region in central Mexico, a research team headed by investigators [Read more]
See what we’re reading this week at Global Biodefense on topics including gain-of-function research guidelines, synthesizing the human genome, and critical health security funding gaps. POLICY, PRACTICES & PREPAREDNESS The edge of the antibiotic [Read more]
University of Virginia School of Medicine researchers have identified promising drugs that could lead to the first antidote for radiation exposure that might result from a dirty bomb terror attack or a [Read more]
© 2018 Global Biodefense